The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Cancer metastases: challenges and opportunities
Open accessAbstract
Cancer metastasis is the major cause of cancer morbidity and mortality, and accounts for about 90% of cancer deaths. Although cancer survival rate has been significantly improved over the years, the improvement is primarily due to early diagnosis and cancer growth inhibition. Limited progress has been made in the treatment of cancer metastasis due to various factors. Current treatments for cancer metastasis are mainly chemotherapy and radiotherapy, though the new generation anti-cancer drugs (predominantly neutralizing antibodies for growth factors and small molecule kinase inhibitors) do have the effects on cancer metastasis in addition to their effects on cancer growth. Cancer metastasis begins with detachment of metastatic cells from the primary tumor, travel of the cells to different sites through blood/lymphatic vessels, settlement and growth of the cells at a distal site. During the process, metastatic cells go through detachment, migration, invasion and adhesion. These four essential, metastatic steps are inter-related and affected by multi-biochemical events and parameters. Additionally, it is known that tumor microenvironment (such as extracellular matrix structure, growth factors, chemokines, matrix metalloproteinases) plays a significant role in cancer metastasis. The biochemical events and parameters involved in the metastatic process and tumor microenvironment have been targeted or can be potential targets for metastasis prevention and inhibition. This review provides an overview of these metastasis essential steps, related biochemical factors, and targets for intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collective cell migration in morphogenesis, regeneration and cancer
Friedl, P., & Gilmour, D. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2720 · Cited by 2,712
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,438
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,386
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Chanmee, T., Ontong, P., Konno, K., & Itano, N. (2014) · Cancers · doi:10.3390/cancers6031670 · Cited by 1,538
On the Origin of Cancer Metastasis
Seyfried, T. N., & Huysentruyt, L. C. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.40 · Cited by 1,196
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2006) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,170
CD44: Structure, Function and Association with the Malignant Process
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60101-3 · Cited by 1,016
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 966
Hazan, R. B., Phillips, G. R., Qiao, R. F., Norton, L., & Aaronson, S. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.4.779 · Cited by 933
N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression
Nieman, M. T., Prudoff, R. S., Johnson, K. R., & Wheelock, M. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.3.631 · Cited by 789
Metastasis: recent discoveries and novel treatment strategies
Eccles, S. A., & Welch, D. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60781-8 · Cited by 721
[2] Families of serine peptidases
Rawlings, N. D., & Barrett, A. J. (1994) · Methods in Enzymology · doi:10.1016/0076-6879(94)44004-2 · Cited by 629
Underhill, C. (1992) · Journal of Cell Science · doi:10.1242/jcs.103.2.293 · Cited by 609
Cadherin Switch in Tumor Progression
HAZAN, R. B., QIAO, R., KEREN, R., BADANO, I., & SUYAMA, K. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.016 · Cited by 595
Axis of evil: molecular mechanisms of cancer metastasis
Bogenrieder, T., & Herlyn, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206757 · Cited by 593
Integrins: roles in cancer development and as treatment targets
Jin, H., & Varner, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601576 · Cited by 574
Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
Jalkanen, S., & Jalkanen, M. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.3.817 · Cited by 530
A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development.
Riethmacher, D., Brinkmann, V, & Birchmeier, C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.855 · Cited by 505
c-Met: Structure, functions and potential for therapeutic inhibition
Ma, P. C., Maulik, G., Christensen, J., & Salgia, R. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023768811842 · Cited by 504
Wood, S. L., Pernemalm, M., Crosbie, P. A., & Whetton, A. D. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.10.001 · Cited by 485
Mechanisms of Motility in Metastasizing Cells
Yilmaz, M., & Christofori, G. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0139 · Cited by 477
CD44, a therapeutic target for metastasising tumours
Orian-Rousseau, V. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.024 · Cited by 474
Selectins promote tumor metastasis
Läubli, H., & Borsig, L. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.04.005 · Cited by 461
Cancer Cell Adhesion and Metastasis: Selectins, Integrins, and the Inhibitory Potential of Heparins
Bendas, G., & Borsig, L. (2012) · International Journal of Cell Biology · doi:10.1155/2012/676731 · Cited by 458
CD44 in Cancer Progression: Adhesion, Migration and Growth Regulation
Marhaba, R., & Zöller, M. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032354.94213.69 · Cited by 438
Invadopodia Are Required for Cancer Cell Extravasation and Are a Therapeutic Target for Metastasis
Leong, H. S., Robertson, A. E., Stoletov, K., Leith, S. J., Chin, C. A., Chien, A. E., Hague, M. N., Ablack, A., Carmine-Simmen, K., McPherson, V. A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.050 · Cited by 400
Schlaepfer, D. D., Jones, K. C., & Hunter, T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2571 · Cited by 397
Tumor suppressor gene E-cadherin and its role in normal and malignant cells
Pećina-Šlaus, N. (2003) · Cancer Cell International · doi:10.1186/1475-2867-3-17 · Cited by 394
Identification of a cadherin cell adhesion recognition sequence
Blaschuk, O. W., Sullivan, R., David, S., & Pouliot, Y. (1990) · Developmental Biology · doi:10.1016/0012-1606(90)90290-y · Cited by 384
Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression
Buchheit, C. L., Weigel, K. J., & Schafer, Z. T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3789 · Cited by 367
Hsu, M.-Y., Meier, F. E., Nesbit, M., Hsu, J.-Y., Van Belle, P., Elder, D. E., & Herlyn, M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65023-7 · Cited by 363
Molecular networks that regulate cancer metastasis
Spano, D., Heck, C., De Antonellis, P., Christofori, G., & Zollo, M. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.03.006 · Cited by 357
A role for cadherins in tissue formation
Larue, L., Antos, C., Butz, S., Huber, O., Delmas, V., Dominis, M., & Kemler, R. (1996) · Development · doi:10.1242/dev.122.10.3185 · Cited by 355
Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?
Micke, P., & tman, A. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.07.977 · Cited by 344
Tube Travel: The Role of Proteases in Individual and Collective Cancer Cell Invasion
Friedl, P., & Wolf, K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0784 · Cited by 338
Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis
Pawelek, J. M., & Chakraborty, A. K. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2371 · Cited by 325
Dual role of the CD44 molecule in T cell adhesion and activation.
Shimizu, Y., Van Seventer, G. A., Siraganian, R., Wahl, L., & Shaw, S. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2457 · Cited by 318
Membrane proteins with immunoglobulin-like domains—a master superfamily of interaction molecules
Barclay, A. N. (2003) · Seminars in Immunology · doi:10.1016/s1044-5323(03)00047-2 · Cited by 309
Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
Fox, S. B., Fawcett, J., Jackson, D. G., Collins, I., Gatter, K. C., Harris, A. L., Gearing, A. J. H., & Simmons, D. L. (1994) · PubMed · Cited by 304
The regulation of MMP targeting to invadopodia during cancer metastasis
Jacob, A., & Prekeris, R. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00004 · Cited by 299
Netzel-Arnett, S., Hooper, J. D., Szabo, R., Madison, E. L., Quigley, J. P., Bugge, T. H., & Antalis, T. M. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023003616848 · Cited by 289
Functions of CXCL12 and CXCR4 in breast cancer
Luker, K. E., & Luker, G. D. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.06.021 · Cited by 288
LFA-3, CD44, and CD45: Physiologic Triggers of Human Monocyte TNF and IL-1 Release
Webb, D. S. A., Shimizu, Y., Van Seventer, G. A., Shaw, S., & Gerrard, T. L. (1990) · Science · doi:10.1126/science.1697984 · Cited by 287
Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical Trials
Fang, H., & DeClerck, Y. A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0661 · Cited by 284
Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report
Duffy, M. J., O'siorain, L., O'grady, P., Devaney, D., Fennelly, J. J., & Lijnen, H. J. (1988) · Cancer · doi:10.1002/1097-0142(19880801)62:3<531::aid-cncr2820620315>3.0.co;2-b · Cited by 282
Shuman Moss, L. A., Jensen-Taubman, S., & Stetler-Stevenson, W. G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.08.044 · Cited by 271
Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
Araujo, J., & Logothetis, C. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.02.015 · Cited by 244
A novel PKC-regulated mechanism controls CD44–ezrin association and directional cell motility
Legg, J. W., Lewis, C. A., Parsons, M., Ng, T., & Isacke, C. M. (2002) · Nature Cell Biology · doi:10.1038/ncb797 · Cited by 238
Park, S. I., Zhang, J., Phillips, K. A., Araujo, J. C., Najjar, A. M., Volgin, A. Y., Gelovani, J. G., Kim, S.-J., Wang, Z., & Gallick, G. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2997 · Cited by 233
Stoeltzing, O., Liu, W., Reinmuth, N., Fan, F., Parry, G. C., Parikh, A. A., McCarty, M. F., Bucana, C. D., Mazar, A. P., & Ellis, L. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10958 · Cited by 224
Mapping proteolytic cancer cell-extracellular matrix interfaces
Wolf, K., & Friedl, P. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9190-2 · Cited by 211
Trochon, V., Mabilat, C., Bertrand, P., Legrand, Y., Smadja-Joffe, F., Soria, C., Delpech, B., & Lu, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960529)66:5<664::aid-ijc14>3.0.co;2-4 · Cited by 211
Khalili, P., Arakelian, A., Chen, G., Plunkett, M. L., Beck, I., Parry, G. C., Doñate, F., Shaw, D. E., Mazar, A. P., & Rabbani, S. A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0100 · Cited by 203
Targeting tumor cell motility as a strategy against invasion and metastasis
Wells, A., Grahovac, J., Wheeler, S., Ma, B., & Lauffenburger, D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.03.001 · Cited by 201
Regulation of Tumor Growth and Metastasis: The Role of Tumor Microenvironment
Goubran, H. A., Kotb, R. R., Stakiw, J., Emara, M. E., & Burnouf, T. (2014) · Cancer Growth and Metastasis · doi:10.4137/cgm.s11285 · Cited by 200
The Role of Immunoglobulin Superfamily Cell Adhesion Molecules in Cancer Metastasis
Wai Wong, C., Dye, D. E., & Coombe, D. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/340296 · Cited by 200
Invading one step at a time: the role of invadopodia in tumor metastasis
Paz, H., Pathak, N., & Yang, J. (2014) · Oncogene · doi:10.1038/onc.2013.393 · Cited by 197
Ganguly, K. K., Pal, S., Moulik, S., & Chatterjee, A. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.23840 · Cited by 192
Hammond, E., Khurana, A., Shridhar, V., & Dredge, K. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00195 · Cited by 192
Targeting the tumor microenvironment: JAK-STAT3 signaling
Bournazou, E., & Bromberg, J. (2013) · JAK-STAT · doi:10.4161/jkst.23828 · Cited by 189
Xue, C., Wyckoff, J., Liang, F., Sidani, M., Violini, S., Tsai, K.-L., Zhang, Z.-Y., Sahai, E., Condeelis, J., & Segall, J. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1242 · Cited by 188
The Clinical Significance of Hypoxia in Human Cancers
Dhani, N., Fyles, A., Hedley, D., & Milosevic, M. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.11.002 · Cited by 188
Matrix metalloproteinase-2 activation modulates glioma cell migration
Deryugina, E. I., Bourdon, M. A., Luo, G.-X., Reisfeld, R. A., & Strongin, A. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.19.2473 · Cited by 182
Targeting anoikis resistance in prostate cancer metastasis
Sakamoto, S., & Kyprianou, N. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.02.001 · Cited by 180
Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy
Barar, J., & Omidi, Y. (2013) · PubMed · doi:10.5681/bi.2013.036 · Cited by 175
Chemotherapy Enhances Metastasis Formation via VEGFR-1–Expressing Endothelial Cells
Daenen, L. G. M., Roodhart, J. M. L., van Amersfoort, M., Dehnad, M., Roessingh, W., Ulfman, L. H., Derksen, P. W. B., & Voest, E. E. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0627 · Cited by 164
Melanoma metastasis: new concepts and evolving paradigms
Damsky, W. E., Theodosakis, N., & Bosenberg, M. (2014) · Oncogene · doi:10.1038/onc.2013.194 · Cited by 164
Cell migration—The role of integrin glycosylation
Janik, M. E., Lityńska, A., & Vereecken, P. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.03.013 · Cited by 162
Metastasis review: from bench to bedside
Alizadeh, A. M., Shiri, S., & Farsinejad, S. (2014) · Tumor Biology · doi:10.1007/s13277-014-2421-z · Cited by 160
Notch Signaling Pathway and Cancer Metastasis
Hu, Y., Zheng, M., Zhang, R., Liang, Y., & Han, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_14 · Cited by 154
ICAM-1 expression determines malignant potential of cancer
Roland, C. L., Harken, A. H., Sarr, M. G., & Barnett, C. C. (2007) · Surgery · doi:10.1016/j.surg.2007.01.016 · Cited by 150
Rennebeck, G., Martelli, M. G., & Kyprianou, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2763 · Cited by 149
Cell migration: mechanisms of rear detachment and the formation of migration tracks
Kirfel, G., Rigort, A., Borm, B., & Herzog, V. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00421 · Cited by 147
Li, D.-M., & Feng, Y.-M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1499-x · Cited by 145
E-cadherin and its associated protein catenins, cancer invasion and metastasis
Jiang, W. G. (1996) · British journal of surgery · doi:10.1002/bjs.1800830404 · Cited by 144
microRNA-mediated regulation of the tumor microenvironment
Chou, J., Shahi, P., & Werb, Z. (2013) · Cell Cycle · doi:10.4161/cc.26087 · Cited by 142
Luo, J., Lubaroff, D. M., & Hendrix, M. J. C. (1999) · PubMed · Cited by 141
Why does cancer therapy lack effective anti-metastasis drugs?
Weber, G. F. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.09.025 · Cited by 139
Microenvironmental regulation of cancer metastasis by miRNAs
Zhang, Y., Yang, P., & Wang, X. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.09.007 · Cited by 139
Lokeshwar, V. B., & Bourguignon, L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55226-1 · Cited by 129
Schaefer, K. L., Wada, K., Takahashi, H., Matsuhashi, N., Ohnishi, S., Wolfe, M. M., Turner, J. R., Nakajima, A., Borkan, S. C., & Saubermann, L. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3037 · Cited by 126
Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines
Omidi, Y., & Barar, J. (2014) · PubMed Central · doi:10.5681/bi.2014.021 · Cited by 123
Livant, D. L., Brabec, R. K., Pienta, K. J., Allen, D. L., Kurachi, K., Markwart, S. M., & Upadhyaya, A. (2000) · PubMed · Cited by 116
Role of CD44 in tumour progression and strategies for targeting
Negi, L. M. S., Talegaonkar, S., Jaggi, M., Ahmad, F. J., Iqbal, Z., & Khar, R. K. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.702767 · Cited by 112
The neurotrophic receptor TrkB: a drug target in anti-cancer therapy?
Desmet, C. J., & Peeper, D. S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5490-8 · Cited by 106
Gavert, N. S., Ben‐Shmuel, A., Raveh, S., & Ben‐Ze'ev, A. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.11.1749 · Cited by 93
Alva, A. S., Slovin, S. F., Daignault, S. D., Carducci, M. A., DiPaola, R. S., Pienta, K. J., Agus, D. B., Cooney, K. A., Chen, A. P., Smith, D. C., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9573-5 · Cited by 88
Multifaceted Roles of Integrins in Breast Cancer Metastasis
White, D. E., & Muller, W. J. (2007) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-007-9045-5 · Cited by 83
Qian, L.-W., Mizumoto, K., Maehara, N., Ohuchida, K., Inadome, N., Saimura, M., Nagai, E., Matsumoto, K., Nakamura, T., & Tanaka, M. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00517-7 · Cited by 73
Revach, O., & Geiger, B. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.27842 · Cited by 68
Zeng, G., Cai, S., & Wu, G. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-113 · Cited by 65
Phosphatidylinositol 3-kinase: a key regulator in adherens junction formation and function
Rivard, N. (2009) · Frontiers in bioscience · doi:10.2741/3259 · Cited by 58
Role of Inflammation-Associated Microenvironment in Tumorigenesis and Metastasis
Gao, F., Liang, B., Reddy, S. T., et al. (2014) · Current Cancer Drug Targets · doi:10.2174/15680096113136660107 · Cited by 56
Keledjian, K. M., & Kyprianou, N. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000042453.12079.77 · Cited by 54
New strategy to control cell migration and metastasis regulated by CCN2/CTGF
Aguiar, D. P., de Farias, G. C., de Sousa, E. B., Coelho‐Aguiar, J. D. M., Lobo, J. C., Casado, P. L., Duarte, M. E. L., & Abreu, J. G. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-61 · Cited by 53
Sulfated Hexasaccharides Attenuate Metastasis by Inhibition of P-selectin and Heparanase
Borsig, L., Vlodavsky, I., Ishai-Michaeli, R., Torri, G., & Vismara, E. (2011) · Neoplasia · doi:10.1593/neo.101734 · Cited by 50
MicroRNAs: Cobblestones on the Road to Cancer Metastasis
Profumo, V., & Gandellini, P. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013007182 · Cited by 45
Zhang, Y., Fujiwara, Y., Doki, Y., Takiguchi, S., Yasuda, T., Miyata, H., Yamazaki, M., Ngan, C. Y., Yamamoto, H., Ma, Q., et al. (2008) · Oncology · doi:10.1159/000151615 · Cited by 39
Undevia, S. D., Vogelzang, N. J., Mauer, A. M., Janisch, L. A., Mani, S., & Ratain, M. J. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000036687.26604.8c · Cited by 37
Zanotti, S., Gibertini, S., Bragato, C., Mantegazza, R., Morandi, L. O., & Mora, M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.08.004 · Cited by 35
Tanaka, K., Mohri, Y., Nishioka, J., Kobayashi, M., Ohi, M., Miki, C., Tonouchi, H., Nobori, T., & Kusunoki, M. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21232 · Cited by 32
The role of the transcriptional regulator snail in cell detachment, reattachment and migration
Haraguchi, M. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.3.8259 · Cited by 27
Naora, H. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00018 · Cited by 20
Cancer metastasis challenges progress and the opportunities
Jiang, W. G. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e254 · Cited by 11
Cited by
Bui, T. M., Wiesolek, H. L., & Sumagin, R. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mr0220-549r · Cited by 957
Yang, Q., Guo, N., Zhou, Y., Chen, J., Wei, Q., & Han, M. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.004 · Cited by 471
Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
Xu, M., Wang, Y., Xia, R., Wei, Y., & Wei, X. (2021) · Cell Proliferation · doi:10.1111/cpr.13115 · Cited by 382
Are cancer cells really softer than normal cells?
Alibert, C., Goud, B., & Manneville, J. (2017) · Biology of the Cell · doi:10.1111/boc.201600078 · Cited by 366
A framework for the development of effective anti-metastatic agents
Anderson, R. L., Balasas, T., Callaghan, J., Coombes, R. C., Evans, J., Hall, J. A., Kinrade, S., Jones, D., Jones, P. S., Jones, R., et al. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0134-8 · Cited by 341
Metadata
- Authors
- Guan, X.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 5
- Issue
- 5
- Pages
- 402-418
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W2209093312
- Cited by
- 952
- References
- 106
- FWCI
- 19.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.